Free Trial

Venture Visionary Partners LLC Purchases 3,784 Shares of Colgate-Palmolive Company $CL

Colgate-Palmolive logo with Consumer Staples background

Key Points

  • Venture Visionary Partners LLC increased its stake in Colgate-Palmolive by 34.4%, owning 14,791 shares valued at approximately $1.39 million as of the latest SEC filing.
  • Colgate-Palmolive reported a $0.92 EPS for the last quarter, surpassing analysts' expectations, and had a revenue increase of 1% year-over-year, totaling $5.11 billion.
  • The company recently announced a $0.52 per share quarterly dividend, reflecting a yield of 2.4%, with a payout ratio of 58.43%.
  • Need better tools to track Colgate-Palmolive? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Venture Visionary Partners LLC raised its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 34.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,791 shares of the company's stock after buying an additional 3,784 shares during the period. Venture Visionary Partners LLC's holdings in Colgate-Palmolive were worth $1,386,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. Personal CFO Solutions LLC acquired a new stake in Colgate-Palmolive during the 1st quarter valued at $285,000. Vision Capital Management Inc. bought a new stake in shares of Colgate-Palmolive during the first quarter worth $322,000. Autumn Glory Partners LLC increased its stake in shares of Colgate-Palmolive by 67.4% in the first quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock valued at $851,000 after buying an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. bought a new position in shares of Colgate-Palmolive in the first quarter valued at about $2,166,000. Finally, Penserra Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 398.6% in the first quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock valued at $997,000 after buying an additional 8,515 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Wall Street Analyst Weigh In

CL has been the topic of a number of research analyst reports. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a report on Monday, August 4th. JPMorgan Chase & Co. decreased their price target on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Citigroup lowered their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a report on Monday, August 4th. Barclays upped their price objective on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 15th. Finally, Morgan Stanley lowered their target price on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Seven analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $98.92.

Read Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Trading Down 0.6%

CL traded down $0.5010 during trading on Friday, reaching $85.7790. 4,087,413 shares of the company's stock were exchanged, compared to its average volume of 5,056,872. The company's fifty day moving average price is $87.60 and its 200-day moving average price is $89.93. The firm has a market capitalization of $69.33 billion, a PE ratio of 24.10, a P/E/G ratio of 4.47 and a beta of 0.35. Colgate-Palmolive Company has a fifty-two week low of $82.40 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the prior year, the business posted $0.91 EPS. The firm's quarterly revenue was up 1.0% on a year-over-year basis. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. The ex-dividend date was Friday, July 18th. Colgate-Palmolive's payout ratio is presently 58.43%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines